Cargando…
Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts
OBJECTIVE: To assess whether quantitative assessment of symptom reduction is a better outcome parameter than cyst volume reduction for treatment success in patients treated by aspiration sclerotherapy. METHODS: We included patients with symptomatic, large (> 5 cm), hepatic cysts from a randomized...
Autores principales: | Neijenhuis, Myrte K., Wijnands, Titus F. M., Kievit, Wietske, Ronot, Maxime, Gevers, Tom J. G., Drenth, Joost P. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510865/ https://www.ncbi.nlm.nih.gov/pubmed/30542749 http://dx.doi.org/10.1007/s00330-018-5851-y |
Ejemplares similares
-
Predictors of treatment response following aspiration sclerotherapy of hepatic cysts: an international pooled analysis of individual patient data
por: Wijnands, Titus F. M., et al.
Publicado: (2016) -
Aspiration sclerotherapy combined with pasireotide to improve reduction of large symptomatic hepatic cysts (SCLEROCYST): study protocol for a randomized controlled trial
por: Wijnands, Titus FM, et al.
Publicado: (2015) -
Ethanol sclerotherapy or polidocanol sclerotherapy for symptomatic hepatic cysts
por: Wijnands, Titus FM, et al.
Publicado: (2018) -
Pasireotide does not improve efficacy of aspiration sclerotherapy in patients with large hepatic cysts, a randomized controlled trial
por: Wijnands, Titus F. M., et al.
Publicado: (2018) -
Impact of liver volume on polycystic liver disease-related symptoms and quality of life
por: Neijenhuis, Myrte K, et al.
Publicado: (2017)